AVITA Medical, Inc. (RCEL)

AVITA Medical Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Jun 30, 2021
Revenue	71.61	64.25	50.14	34.42	29.23
Revenue Growth (YoY)	11.45%	28.14%	45.68%	17.75%	104.95%
Cost of Revenue	12.79	9.09	7.78	6.04	5.95
Gross Profit	58.82	55.16	42.36	28.38	23.28
Selling, General & Admin	80.51	91.39	65.63	45.24	37.06
Research & Development	20.84	20.36	20.82	13.86	14.82
Other Operating Expenses	-	-	-1.43	-3.22	-2.06
Total Operating Expenses	101.35	111.75	85.02	55.89	49.82
Operating Income	-42.53	-56.59	-42.66	-27.51	-26.54
Interest Income	-	-	8.48	0.89	0.02
Interest Expense	-5	-5.36	-1.14	-0.02	-0.02
Other Non-Operating Income (Expense)	-1.04	0.16	-	-	-
Total Non-Operating Income (Expense)	-6.04	-5.2	7.34	0.88	-0.01
Pretax Income	-48.58	-61.79	-35.32	-26.63	-26.55
Provision for Income Taxes	0.01	0.05	0.07	0.04	0.04
Net Income	-48.59	-61.85	-35.38	-26.67	-26.58
Net Income to Common	-48.59	-61.85	-35.38	-26.67	-26.58
Shares Outstanding (Basic)	1	1	1	1	1
Shares Outstanding (Diluted)	1	1	1	1	1
Shares Change (YoY)	7.64%	2.18%	1.32%	10.26%	11.75%
EPS (Basic)	-34.80	-47.80	-28.00	-21.40	-23.40
EPS (Diluted)	-34.80	-47.80	-28.00	-21.40	-23.40
Shares Outstanding	1.52	1.32	1.28	1.26	1.24
Free Cash Flow	-48.59	-61.85	-35.38	-26.67	-26.58
Free Cash Flow Per Share	-34.88	-47.79	-27.93	-21.33	-23.45
Gross Margin	82.13%	85.85%	84.48%	82.45%	79.65%
Operating Margin	-59.40%	-88.08%	-85.07%	-79.91%	-90.79%
Profit Margin	-67.85%	-96.26%	-70.56%	-77.47%	-90.94%
FCF Margin	-67.85%	-96.26%	-70.56%	-77.47%	-90.94%
EBITDA	-42.53	-56.59	-42.66	-27.51	-26.54
EBIT	-42.53	-56.59	-42.66	-27.51	-26.54
EBIT Margin	-59.40%	-88.08%	-85.07%	-79.91%	-90.79%
Effective Tax Rate	-0.02%	-0.09%	-0.19%	-0.14%	-0.14%

Updated Feb 13, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q